Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1462 participants.

Also called NCT03067441

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,462 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03067441
  • EudraCT 2016-004115-12
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03067441. Allocation not applicable; no masking; primary purpose treatment. Start 2017-02-03 (actual); primary completion 2019-11-05 (actual). Results posted on 2020-12-22.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
Condition
Hypercholesterolemia
Condition
Atherosclerotic Cardiovascular Disease
Intervention (Drug)
bempedoic acid
Lead sponsor
Esperion Therapeutics, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03067441
Content hash
93f775726760a4d2e71bbae70a1ab83e2547d4d6f64927c97da1ffccebea8b2b